<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7485949\results\search\testTrace\results.xml">
  <result pre="risk of bias.3 COVIDâ€�19 is a historic pandemic that is" exact="testing" post="populations, healthcare systems, and the biopharmaceutical industry in previously"/>
  <result pre="in full force to consider approaches to treat and prevent" exact="infection" post="with SARSâ€�CoVâ€�2. Vaccines, which if effective will result in"/>
  <result pre="nonbinding recommendations for CP donation: donors must have had documented" exact="infection" post="with SARSâ€�CoVâ€�2 (realâ€�time polymerase chain reaction or serology) and"/>
  <result pre="donation: donors must have had documented infection with SARSâ€�CoVâ€�2 (realâ€�time" exact="polymerase chain reaction" post="or serology) and at least 28Â days from resolution"/>
  <result pre="at least 14Â days without symptoms and a negative realâ€�time" exact="polymerase chain reaction" post="test.4 CP has been used compassionately in this pandemic"/>
  <result pre="that a single infusion of Hâ€�IG may be sufficient for" exact="treatment" post="in the acute disease settings. In upcoming studies, it"/>
  <result pre="new, emerging epidemics. Target indications for the COVIDâ€�19 Hâ€�IG include" exact="treatment" post="and prevention. In coronavirus diseases, including COVIDâ€�19, endogenous antibody"/>
  <result pre="would come from Hâ€�IG. Randomized, placebo controlled clinical trials in" exact="treatment" post="paradigms are anticipated to begin in Summer 2020. In"/>
  <result pre="To date, several hundred HCPs have died from COVIDâ€�19.8 High" exact="infection" post="rates in HCPs translate to direct and indirect harm:"/>
  <result pre="describes two basic phenomena mediated by virusâ€�specific antibodies: enhanced viral" exact="infection" post="and enhanced immunologic response in the advanced disease, independent"/>
  <result pre="1Bloch, E.M.et al.Deployment of convalescent plasma for the prevention and" exact="treatment" post="of COVIDâ€�19. J. Clin. Invest (2020). 10.1172/JCI138745 2Lai, S.T.Treatment"/>
  <result pre="al.The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the" exact="treatment" post="of severe acute respiratory infections of viral etiology: a"/>
  <result pre="9Jaume, M.et al.Antiâ€�severe acute respiratory syndrome coronavirus spike antibodies trigger" exact="infection" post="of human immune cells via a pHâ€� and cysteine"/>
 </snippets>
</snippetsTree>
